Autosomal Dominant Polycystic Kidney Disease Treatment Market Set to Reach USD 2,140 Million by 2033 at a 5.97% of CAGR, Driven by Increased Awareness and Advancements in Therapeutics
The global autosomal dominant polycystic kidney disease (ADPKD) treatment market is on track for significant